Movetis NV: Paris (ots/PRNewswire) -
- Novel Compound Offers Hope to Patients not Adequately Responding
to Laxative Treatment
Data presented for the first time today at the international
gastroenterology meeting UEGW (United European Gastroenterology Week)
confirm the effectiveness and safety of RESOLOR(R) (prucalopride), a
novel and selective, high-affinity 5-HT(4) receptor agonist, for
patients suffering from Chronic Constipation (CC) for ...

presseportal.de